Aged Mice Devoid of the M
M3
cornea
dry eye disease
muscarinic receptor
tear secretion
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
07 Jun 2021
07 Jun 2021
Historique:
received:
31
01
2021
revised:
28
05
2021
accepted:
03
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
27
7
2021
Statut:
epublish
Résumé
The parasympathetic nervous system is critically involved in the regulation of tear secretion by activating muscarinic acetylcholine receptors. Hence, various animal models targeting parasympathetic signaling have been developed to induce dry eye disease (DED). However, the muscarinic receptor subtype (M
Identifiants
pubmed: 34200187
pii: ijms22116133
doi: 10.3390/ijms22116133
pmc: PMC8201107
pii:
doi:
Substances chimiques
Reactive Oxygen Species
0
Receptor, Muscarinic M3
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Stem Cells Int. 2017;2017:4923426
pubmed: 28874911
PLoS One. 2015 May 29;10(5):e0126561
pubmed: 26024535
Curr Eye Res. 1998 Dec;17(12):1135-42
pubmed: 9872535
J Ocul Pharmacol Ther. 2005 Apr;21(2):139-48
pubmed: 15857280
Prog Retin Eye Res. 2002 Jan;21(1):1-14
pubmed: 11906808
Am J Pathol. 2012 May;180(5):1879-96
pubmed: 22440255
Exp Eye Res. 2009 Aug;89(2):166-71
pubmed: 19298814
Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3492-9
pubmed: 21421863
Am J Pathol. 2005 Jan;166(1):61-71
pubmed: 15632000
Invest Ophthalmol Vis Sci. 2002 Mar;43(3):632-8
pubmed: 11867577
Ophthalmology. 2017 Nov;124(11S):S4-S13
pubmed: 29055361
Invest Ophthalmol Vis Sci. 2011 Aug 09;52(9):6279-85
pubmed: 21474767
Sci Rep. 2018 Jan 24;8(1):1483
pubmed: 29367638
J Immunol. 2006 Apr 1;176(7):3950-7
pubmed: 16547229
Br J Ophthalmol. 2001 Feb;85(2):147-53
pubmed: 11159476
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3203-9
pubmed: 19255163
Int Ophthalmol Clin. 2017 Spring;57(2):1-12
pubmed: 28282310
Invest Ophthalmol Vis Sci. 1998 Jan;39(1):151-6
pubmed: 9430556
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2553-60
pubmed: 17525184
Molecules. 2019 Feb 22;24(4):
pubmed: 30813289
Ann Rheum Dis. 1996 Sep;55(9):612-5
pubmed: 8882130
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4293-301
pubmed: 15557435
Ocul Surf. 2019 Jan;17(1):9-19
pubmed: 30419303
Invest Ophthalmol Vis Sci. 2014 Sep 25;55(10):6829-38
pubmed: 25257053
Dev Ophthalmol. 2008;41:298-312
pubmed: 18453777
Annu Rev Pharmacol Toxicol. 2004;44:423-50
pubmed: 14744253
Oxid Med Cell Longev. 2019 Dec 29;2019:9736047
pubmed: 31976030
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1552-8
pubmed: 17389484
J Histochem Cytochem. 2008 Dec;56(12):1099-111
pubmed: 18796405
Int J Mol Med. 2018 Mar;41(3):1427-1436
pubmed: 29286080
Sci Rep. 2018 Dec 13;8(1):17828
pubmed: 30546125
Am J Physiol Cell Physiol. 2018 Nov 1;315(5):C757-C765
pubmed: 30257104
Nat Rev Drug Discov. 2014 Jul;13(7):549-60
pubmed: 24903776
Am J Pathol. 2014 Mar;184(3):631-43
pubmed: 24389165
Exp Eye Res. 2001 Oct;73(4):449-59
pubmed: 11825017
Nat Rev Drug Discov. 2007 Sep;6(9):721-33
pubmed: 17762886
Angiogenesis. 2015 Oct;18(4):499-510
pubmed: 26310512
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES163-DES168
pubmed: 30481822
Cornea. 2015 Jul;34(7):739-44
pubmed: 25909238
Histopathology. 2002 Jan;40(1):2-11
pubmed: 11903593
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1196-1207
pubmed: 28245300
Biomolecules. 2020 Feb 18;10(2):
pubmed: 32085536
Invest Ophthalmol Vis Sci. 1988 Mar;29(3):374-8
pubmed: 3343094
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2506-12
pubmed: 10509643
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4223-9
pubmed: 14507865
Nature. 2001 Mar 8;410(6825):207-12
pubmed: 11242080
Int J Mol Sci. 2019 Sep 21;20(19):
pubmed: 31546635
Ocul Surf. 2017 Jul;15(3):438-510
pubmed: 28736340
Medicine (Baltimore). 2020 Sep 11;99(37):e22234
pubmed: 32925801
Adv Exp Med Biol. 2002;506(Pt A):647-55
pubmed: 12613973
Cornea. 1997 Nov;16(6):645-8
pubmed: 9395874
Invest Ophthalmol Vis Sci. 2013 Nov 15;54(12):7557-66
pubmed: 24052636